More Frequent Scans Not Linked to Improved Survival After Lung Cancer Surgery

WEDNESDAY, Dec. 7, 2022 (HealthDay News) -- For veterans with pathologic stage I non-small cell lung cancer receiving surgery, more frequent surveillance after surgery is not associated with improved survival, according to a study published online Nov. 29 in the Journal of the National Cancer Institute.
Brendan T. Heiden, M.D., from the Washington University School of Medicine in St. Louis, and colleagues conducted a retrospective cohort study of veterans with pathologic stage I non-small cell lung cancer receiving surgery to examine the association between surveillance frequency (chest computed tomography [CT] scans within two years after surgery) and recurrence-free and overall survival. Data were included for 6,171 patients: 49.4 and 50.6 percent underwent low-frequency (fewer than two scans/year) and high-frequency (two or more scans/year) surveillance, respectively.
The researchers found that being a former versus current smoker, receiving a wedge resection versus lobectomy, and having follow-up with an oncologist were factors associated with high-frequency surveillance; African American versus White race was associated with low-frequency surveillance. Recurrence was detected in 22.0 percent of patients, with a median follow-up of 7.3 years. There was no association seen for high-frequency surveillance with longer recurrence-free or overall survival.
"Our findings suggest that lung cancer treatment guidelines should consider less frequent surveillance imaging than current recommendations," a coauthor said in a statement. "Annual surveillance would simplify guidelines and may result in better, easier postoperative care for early-stage patients."
Abstract/Full Text (subscription or payment may be required)
Related Posts
Por primera vez, un robot realiza una cirugía laparoscópica en cerdos, sin ayuda humana
VIERNES, 28 de enero de 2022 (HealthDay News) -- Un robot realizó una difícil...
Una boca sana le puede salvar la vida a los niños con afecciones cardiacas
MIÉRCOLES, 16 de febrero de 2022 (HealthDay News) -- Los niños que sufren de...
CVS y Walgreens anuncian acuerdos de 10 mil millones de dólares por los opioides
MIÉRCOLES, 2 de noviembre de 2022 (HealthDay News) -- Años de litigio sobre la...
U.S. Adults Lack Knowledge About Age-Related Macular Degeneration
WEDNESDAY Feb. 8, 2023 (HealthDay News) -- Most U.S. adults are unaware of...